Ask Me Anything: Organoids

Join us for an exciting live Ask Me Anything (AMA) session with Dr. Thomas Hartung, MD, PhD, a distinguished professor at Johns Hopkins Bloomberg School of Public Health. This event will delve into the groundbreaking field of organoid research, a rapidly evolving technology that is revolutionizing biomedical science. During this interactive session, Dr. Hartung will discuss how organoids (miniature, lab-grown versions of organs) are transforming personalized medicine, drug screening and disease modeling. Discover how this innovative approach is reducing the need for animal testing and accelerating translational research, ultimately bringing new treatments from the lab to the clinic faster and more effectively. What to Expect: • Insightful discussions on the latest advances in organoid technology • Real-world applications in medicine and pharmaceutical development • The opportunity to ask Dr. Hartung your own questions in a dynamic live format • A deeper understanding of how organoids are shaping the future of healthcare Curious how organoid technology is reshaping translational science? Join us on July 28 for a live Ask Me Anything with Dr. Thomas Hartung from Johns Hopkins Bloomberg School of Public Health – who’s leading the global conversation on 3D cell culture and its role in precision models of human biology. What you’ll explore: • How organoids are accelerating personalized therapies • Their role in bridging in vitro findings to clinical outcomes • Why they’re quickly replacing traditional animal models Organoids are transforming how we design, test and deliver patient-specific treatments—and Dr. Thomas Hartung is at the forefront of that movement. On July 28th, you’re invited to a live Ask Me Anything with Dr. Hartung (Johns Hopkins), focused on how organoids are being used in cell therapy and precision medicine. Join to explore: • Patient-derived organoids as predictive therapy platforms • The integration of organoids in personalized oncology and rare disease • How this tech is helping phase out outdated models Come with your toughest questions. Leave with cutting-edge insights. Thomas Hartung, MD PhD, is professor at Johns Hopkins Bloomberg School of Public Health in Environmental Health & Engineering as well as Molecular Microbiology and Immunology, the Whiting School of Engineering and the School of Medicine In Cellular and Molecular Medicine, as well as Georgetown University, Washington D.C., in Environmental Metrology and Policy, and University of Konstanz, Germany, in Pharmacology and Toxicology; he also is Director of Centers for Alternatives to Animal Testing (CAAT) in the US and Europe and Field Chief Editor of Frontiers in AI. He authored 730+ scientific publications with 52,000+ citations (h-index 123) and his COURSERA toxicology classes had 22,000+ active learners.